Sponsor:
Wake Forest University Health Sciences
Code:
NCT06945042
Conditions
Acute Myeloid Leukemia
Eligibility Criteria
Sex: All
Age: 18 - 64
Healthy Volunteers: Not accepted
Interventions
Arm A
Arm B
Brief summary:
Conditions
Acute Myeloid Leukemia
Study ID
NCT06945042
Start date
Jun 27, 2025
Status verified date
Jul, 2026
Completion date
May, 2028
Anticipated
Primary completion date
May, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 64
Healthy Volunteers: Not accepted
Enrollment
120 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
other: Systematic Financial Navigation
other: Standard of Care Financial Distress Intervention
Interventions
Arm A
Arm B
Primary outcome measure
Central contacts
Locations
Levine Cancer Insitute
Recruiting
Charlotte, North Carolina, United States, 28204
Contacts
Courtney Schepel
Courtney.Schepel@advocatehealth.orgPrincipal Investigator:
Thomas Knight, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Recruiting
Winston-Salem, North Carolina, United States, 27103
Contacts
Sponsor
Wake Forest University Health Sciences
Last update posted
Jul 23, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2026-07-23.